文献速递哮喘慢阻肺

从初潮到绝经:女性生殖里程碑与慢性气道疾病风险的叙述性综述

From Menarche to Menopause: A Narrative Review of Female Reproductive Milestones and Risk of Chronic Airway Disease.
PubMed 文献 · Chest · 2026-10-05

本文为叙述性综述,探讨女性生殖里程碑与慢性气道疾病风险的关系。早期初潮与成年肺功能降低及哮喘发病率升高相关;多囊卵巢综合征、不良妊娠结局、外源性激素及早期绝经均可能影响哮喘和慢阻肺易感性,肥胖是主要混杂因素。需专门的生命历程队列结合深度表型与激素谱分析来阐明交互作用。

要点

  • 早期初潮与成年肺功能降低及哮喘发病率升高相关。
  • 肥胖是生殖因素与气道疾病关联中的主要混杂因素。
  • 外源性激素对气道影响复杂,因制剂、时机和 duration 而异。

核心结论

  • 女性生殖因素可能影响慢性气道疾病易感性,涉及多条通路,肥胖是主要混杂因素。

研究设计与样本

  • 叙述性综述,未报告系统检索策略或样本量。

主要发现

  • 早期初潮与成年肺功能降低及哮喘发病率升高相关。
  • 多囊卵巢综合征与哮喘风险增加相关,尤其在肥胖个体中。
  • 不良妊娠结局与较低肺功能及未来哮喘和慢阻肺易感性升高相关。
  • 激素避孕可能在瘦型女性中降低哮喘风险,但在肥胖中增加风险。
  • 早期绝经与肺功能加速下降、肥胖者哮喘发病率升高及慢阻肺风险增加相关。

关键数值与推荐

  • 仅雌激素的绝经激素治疗,尤其在较年轻时、绝经前开始或使用时间较长时,可能增加哮喘风险。
  • 激素避孕可能通过稳定雌激素和孕激素波动在瘦型女性中降低哮喘风险。
  • 外源性雌激素在肥胖中可能放大气道炎症而增加哮喘风险。

临床怎么用

  • 呼吸科评估女性患者时应关注生殖史(初潮年龄、绝经状态、激素使用)及肥胖状态。
  • 对使用激素避孕或绝经激素治疗的女性,需结合体重和用药时机个体化评估哮喘风险。

局限性

  • 为叙述性综述,未报告系统检索方法或证据等级。
  • 关系涉及多条通路且肥胖为主要混杂因素,因果推断受限。
  • 需专门的生命历程队列结合深度表型与激素谱分析来阐明交互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC IMPORTANCE: Female reproductive factors are underrecognized determinants of lifelong respiratory health. This narrative review examines relationships between reproductive milestones and chronic airway disease risk. REVIEW FINDINGS: Early menarche is associated with reduced adult lung function and a higher incidence of asthma. Polyendocrine metabolic ovarian syndrome is also associated with increased asthma risk, particularly in obese individuals, through sex hormone dysregulation, metabolic dysfunction, and chronic low-grade inflammation. Adverse pregnancy outcomes are associated with lower lung function and heightened future asthma and chronic obstructive pulmonary disease (COPD) susceptibility, potentially from persistent systemic inflammation, endothelial injury, and oxidative stress beyond the perinatal period. Effects of exogenous sex hormones on the airways are complex and context-dependent. Hormonal contraception may reduce asthma risk in lean females by stabilizing estrogen and progesterone fluctuations, but increase risk in obesity, as exogenous estrogen can amplify airway inflammation. Similarly, effects of menopause hormone therapy (MHT) vary by formulation, timing of initiation, and use duration. Estrogen-only MHT - particularly when started at younger ages, before menopause, or used for longer duration - may increase asthma risk. Early menopause is linked to accelerated lung function decline, higher asthma incidence among those with obesity, and increased COPD risk. SUMMARY: Female reproductive factors may influence susceptibility to chronic airway disease, although these relationships involve multiple pathways, with obesity as a major confounder. A dedicated life-course cohort with deep phenotyping and hormone profiling is needed to elucidate how reproductive exposures, sex hormones, metabolic determinants and other susceptibility factors interact to shape respiratory outcomes in females.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Sridhar S, Riggs K, Kaley A, et al. From Menarche to Menopause: A Narrative Review of Female Reproductive Milestones and Risk of Chronic Airway Disease. Chest. 2026. PMID: 42833548. doi:10.1016/j.chest.2026.09.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。